Exhibit 1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13D, dated May 17, 2019, with respect to the ordinary shares of NextCure, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 20th day of May 2019.
| ORBIMED ADVISORS LLC | |
| | | | |
| | | | |
| | By: | /s/ Jonathan Silverstein | |
| | | Name: Jonathan Silverstein | |
| | | Title: Member of OrbiMed Advisors LLC | |
| | | | |
| | ORBIMED CAPITAL GP VI LLC | |
| | | | |
| | By: | ORBIMED ADVISORS LLC, its managing member |
| | | | |
| | | Member of OrbiMed Advisors LLC | |
| | | |
| | By: | /s/ Jonathan Silverstein | |
| | | Jonathan Silverstein | |
| | | Title: Member of OrbiMed Advisors LLC
| |
